Information Library
Clinical and marketing materials
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
QUINTILES SPEEDS PATIENT RECRUITMENT WITH LOCAL MARKETING AUTOMATION TECHNOLOGY
Quintiles today launched innovative, web-based technology to enable world-class marketing for clinical trial enrollment at an individual site-level. Named Quintiles Trial Enrollment Accelerator (QTEA), this new solution will speed patient recruitment by helping customers better manage the quality, consistency and effectiveness of messaging and media outreach.
-
QUINTILES EXECUTIVE ELECTED CHAIR-ELECT OF CDISC
January 19, 2010 – Quintiles announced that Paula Brown Stafford, Executive Vice President, Integrated Clinical Services, has been elected chair-elect of the Board of Directors of CDISC, a global organization that leads the development of standards to reduce complexity in biomedical research to speed new therapies to market and improve the flow of research information to healthcare.
-
Emerging Markets
September 29, 2009
If you’re looking for new ways to bring development costs down, you may be considering the advantages of conducting clinical trials in emerging markets. -
Treatment Satisfaction Questionnaire
September 25, 2009
When evaluating the quality of programs, services, and products, patient satisfaction is a useful patient reported outcome. It serves four interrelated but distinct purposes, permitting: 1) evaluation of the acceptability of care or treatments from the patients’ perspective; 2) comparison of health-care programs or treatment options; 3) identification of service or treatment approaches that require change; 4) screening of patients who are likely to become nonadherent to care plans or medication regimens For these reasons, satisfaction measures are often used to plan health-care delivery systems and develop pharmaceutical products or medical devises. -
Chemotherapy launch in the US
September 23, 2009
This major pharma company managed to meet all its market milestones thanks to a comprehensive fast track education program in toxicity management - spanning medical and radiation oncology nurses and infusion centre personnel. -
Cardiovascular management in the UK
September 23, 2009
This case study reviews how a Primary Care Trust used a combination of social marketing and Nurse Advisors to bring cardiovascular care to local communities. -
Rheumatoid Arthritis in Germany
September 23, 2009
This program looks at how a major US pharmaceutical company used a nurse advisor program starting in 2009 to train patients to self-administer injections by syringe or pen. -
Controlling Diabetes in Spain
September 23, 2009
Spain has a real problem with diabetes: up to 10% of the population has the disease and it’s a killer, representing the 3rd highest cause of death amongst women. -
Asthma controlled in Poland
September 23, 2009
This case study reviews a 2007 pilot program using nurse advisors to identify patients with uncontrolled asthma in Poland. -
Post-Marketing Commitment Study
June 30, 2009
Quintiles developed creative and effective solutions to deliver quality data, cost efficiently and ahead of schedule.
